Literature DB >> 1349407

Amylin concentrations and glucose control.

J E Koda, M Fineman, T J Rink, G E Dailey, D B Muchmore, L G Linarelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1349407     DOI： 10.1016/0140-6736(92)90785-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  37 in total

1.  Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates.

Authors:  Nicholas T Bello; Matthew H Kemm; Erica M Ofeldt; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-16       Impact factor: 3.619

2.  Amperometric immunoassay for the obesity biomarker amylin using a screen printed carbon electrode functionalized with an electropolymerized carboxylated polypyrrole.

Authors:  Gonzalo Martínez-García; Esther Sánchez-Tirado; Araceli González-Cortés; Paloma Yáñez-Sedeño; José M Pingarrón
Journal:  Mikrochim Acta       Date:  2018-06-09       Impact factor: 5.833

3.  Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys.

Authors:  Nicholas T Bello; Matthew H Kemm; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-14       Impact factor: 3.619

Review 4.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

Review 5.  GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities.

Authors:  Jonathan D Roth; Mary R Erickson; Steve Chen; David G Parkes
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 6.  Neuroendocrine hormone amylin in diabetes.

Authors:  Xiao-Xi Zhang; Yan-Hong Pan; Yan-Mei Huang; Hai-Lu Zhao
Journal:  World J Diabetes       Date:  2016-05-10

Review 7.  Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.

Authors:  C Oosterwijk; J W Höppener; K L van Hulst; C J Lips
Journal:  Int J Pancreatol       Date:  1995-08

8.  Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa.

Authors:  Monica H Wojcik; Erinne Meenaghan; Elizabeth A Lawson; Madhusmita Misra; Anne Klibanski; Karen K Miller
Journal:  Bone       Date:  2009-11-18       Impact factor: 4.398

9.  Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes.

Authors:  Matthew Riddle; Richard Pencek; Supoat Charenkavanich; Karen Lutz; Ken Wilhelm; Lisa Porter
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

10.  Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes.

Authors:  Gina Ryan; Tim A Briscoe; Lynette Jobe
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.